Hubei Goto Biopharm Co.,Ltd.

SZSE:300966.SZ

21.06 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017
Revenue 566.399604.571590.885468.117464.802437.302333.692
Cost of Revenue 441.279466.352434.975361.494333.114306.327231.702
Gross Profit 125.121138.22155.911106.624131.688130.975101.99
Gross Profit Ratio 0.2210.2290.2640.2280.2830.30.306
Reseach & Development Expenses 38.09945.14737.12321.60426.05627.10423.464
General & Administrative Expenses 16.7615.07518.53-6.118-40.602-29.605-14.629
Selling & Marketing Expenses 7.0654.9075.4713.4544.4674.2733.341
SG&A 23.82519.98224.001-2.664-36.135-25.331-11.288
Other Expenses -0.414-0.3923.40510.06536.65831.96119.093
Operating Expenses 83.35485.2983.47340.70538.84344.29339.988
Operating Income 19.5338.90462.71257.379.69578.33355.209
Operating Income Ratio 0.0340.0640.1060.1220.1710.1790.165
Total Other Income Expenses Net -0.414-0.3923.4052.9423.1172.0530.432
Income Before Tax 19.11638.51486.11760.24282.81180.38655.642
Income Before Tax Ratio 0.0340.0640.1460.1290.1780.1840.167
Income Tax Expense -2.174-0.9828.0517.0479.8159.7088.203
Net Income 23.00540.20578.33153.28972.99670.67847.439
Net Income Ratio 0.0410.0670.1330.1140.1570.1620.142
EPS 0.20.350.680.460.630.841.03
EPS Diluted 0.20.350.680.460.630.841.03
EBITDA 72.6382.906118.60696.423128.145120.61586.704
EBITDA Ratio 0.1280.1370.2010.2060.2760.2760.26